Targeted Therapy
Approved for: NSCLC
Biomarker: ALK
Ceritinib (Zykadia) is a FDA-approved Targeted Therapy for Non-small cell lung cancer (NSCLC) that is ALK positive and has metastasized (spread to other parts of the body). It is used in adults.
FDA-Approved Lung Cancer Treatments
Ceritinib (Zykadia)
I want to give in honor of...
name or relation
Donation Amount
other amount